Susquehanna International Group, LLP Atossa Therapeutics, Inc. Transaction History

Susquehanna International Group, LLP

$688 Billion
Q2 2025

A detailed history of Susquehanna International Group, LLP transactions in Atossa Therapeutics, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 273,915 shares of ATOS stock, worth $271,175. This represents 0.0% of its overall portfolio holdings.

Number of Shares

273,915

Previous 440,335 37.79%

Holding current value

$271,175

Previous $295,000 23.05%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$0.59 - $1.03 $98,187 - $171,412	-166,420 Reduced 37.79%	273,915 $227,000
Q1 2025 May 14, 2025	BUY	$0.67 - $1.01 $143,486 - $216,300	214,159 Added 94.69%	440,335 $295,000
Q4 2024 Feb 14, 2025	BUY	$0.94 - $1.62 $145,139 - $250,134	154,404 Added 215.13%	226,176 $212,000
Q3 2024 Nov 14, 2024	BUY	$1.09 - $1.52 $78,231 - $109,093	71,772 New	71,772 $109,000
Q1 2024 May 07, 2024	BUY	$0.8 - $1.89 $53,736 - $126,951	67,170 Added 32.77%	272,115 $489,000
Q4 2023 Feb 14, 2024	SELL	$0.63 - $0.98 $27,442 - $42,687	-43,559 Reduced 17.53%	204,945 $180,000
Q3 2023 Nov 14, 2023	SELL	$0.74 - $1.35 $92,150 - $168,112	-124,528 Reduced 33.38%	248,504 $183,000
Q2 2023 Aug 11, 2023	BUY	$0.6 - $1.28 $160,434 - $342,259	267,390 Added 253.11%	373,032 $470,000
Q1 2023 May 16, 2023	BUY	$0.59 - $0.91 $5,399 - $8,328	9,152 Added 9.48%	105,642 $76,000
Q4 2022 Feb 14, 2023	BUY	$0.5 - $1.01 $48,245 - $97,454	96,490 New	96,490 $51,000
Q2 2022 Aug 15, 2022	SELL	$0.85 - $1.28 $22,944 - $34,552	-26,994 Reduced 25.7%	78,052 $85,000
Q1 2022 May 16, 2022	BUY	$1.11 - $1.74 $36,521 - $57,249	32,902 Added 45.61%	105,046 $131,000
Q4 2021 Feb 14, 2022	SELL	$1.6 - $3.27 $279,795 - $571,831	-174,872 Reduced 70.79%	72,144 $115,000
Q3 2021 Nov 15, 2021	SELL	$2.89 - $6.4 $6.78 Million - $15 Million	-2,345,161 Reduced 90.47%	247,016 $805,000
Q2 2021 Aug 11, 2021	BUY	$1.52 - $8.62 $3.87 Million - $21.9 Million	2,542,921 Added 5162.66%	2,592,177 $16.4 Million
Q1 2021 May 17, 2021	SELL	$0.92 - $4.33 $53,538 - $251,980	-58,194 Reduced 54.16%	49,256 $104,000
Q4 2020 Feb 16, 2021	BUY	$0.85 - $2.43 $47,930 - $137,025	56,389 Added 110.43%	107,450 $102,000
Q3 2020 Nov 16, 2020	SELL	$1.98 - $4.35 $40,180 - $88,274	-20,293 Reduced 28.44%	51,061 $124,000
Q2 2020 Aug 14, 2020	BUY	$1.04 - $4.05 $74,208 - $288,983	71,354 New	71,354 $271,000
Q3 2018 Nov 14, 2018	SELL	$1.47 - $2.78 $35,518 - $67,170	-24,162 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$2.2 - $5.28 $53,156 - $127,575	24,162 New	24,162 $53,000

Others Institutions Holding ATOS

# of Institutions

Shares Held

28.6M

Call Options Held

12.7K

Put Options Held

92.9K

View Full List

About ATOSSA THERAPEUTICS, INC.

Ticker ATOS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,624,000
Market Cap $125M
Description
Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing A...

More about ATOS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Atossa Therapeutics, Inc. Transaction History